Cargando…
Comparison of Apple Watch vs KardiaMobile: A Tale of Two Devices
BACKGROUND: The Apple Watch Series 4 (AW4) and the KardiaMobile single bipolar lead model (KM) are 2 of the most popular US Food & Drug Administration (FDA)-approved commercial heart trackers. However, a lack of knowledge remains regarding their rhythm-detection accuracy in real-life clinical si...
Autores principales: | Lee, Calvin, Lee, Charles, Fernando, Carlos, Chow, Chi-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9700214/ https://www.ncbi.nlm.nih.gov/pubmed/36444370 http://dx.doi.org/10.1016/j.cjco.2022.07.011 |
Ejemplares similares
-
Increasing Early Cardiac Screening in an Inpatient Psychiatric Setting Using the KardiaMobile 6 Lead Device
por: Pierscionek, Tomasz, et al.
Publicado: (2023) -
Recurrent atrial fibrillation/flutter detection after ablation or cardioversion using the AliveCor KardiaMobile device: iHEART results
por: Goldenthal, Isaac L., et al.
Publicado: (2019) -
Feasibility of using KardiaMobile-L6 for QT interval monitoring during the early phase of the COVID-19 pandemic in critical care patients
por: Zaballos, Matilde, et al.
Publicado: (2023) -
Improving the utility and sustainability of novel health technology to improve clinical outcomes for patients: an East Staffordshire experience of screening for atrial fibrillation with the AliveCor KardiaMobile
por: Mathew, Savio, et al.
Publicado: (2021) -
Kardia Mobile applicability in clinical practice: A comparison of Kardia Mobile and standard 12-lead electrocardiogram records in 100 consecutive patients of a tertiary cardiovascular care center
por: Koltowski, Lukasz, et al.
Publicado: (2021)